Angiodynamics (ANGO) Non-Current Deferred Tax Liability (2013 - 2026)

Angiodynamics has reported Non-Current Deferred Tax Liability for 14 years, with the latest figure at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 8.35% year-over-year to $4.6 million; the trailing twelve-month figure through Feb 2026 stood at $4.6 million (up 8.35% YoY), and the FY2025 full-year result was $4.1 million, down 16.06% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $4.6 million, up from $4.3 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $17.8 million in Q4 2023, with the low at $1.3 million in Q3 2023.
• Historically, Non-Current Deferred Tax Liability has averaged $8.8 million across 5 years, with a median of $4.9 million in 2024.
• Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability sank 91.54% — and 2024, when it surged 261.69%.
• Angiodynamics' Non-Current Deferred Tax Liability stood at $14.3 million in 2022, then climbed by 24.27% to $17.8 million in 2023, then slumped by 75.59% to $4.3 million in 2024, then retreated by 0.07% to $4.3 million in 2025, then climbed by 5.15% to $4.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $4.6 million (Q1 2026), $4.3 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.